Search by Drug Name or NDC
NDC 00019-1188-81 SODIUM CHLORIDE 0.9 mg/mL Details
SODIUM CHLORIDE 0.9 mg/mL
SODIUM CHLORIDE is a INTRAVASCULAR INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Liebel-Flarsheim Company LLC. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 00019-1188 |
|---|---|
| Product ID | 0019-1188_cdff7813-7b00-4f61-a017-18ab8910d49d |
| Associated GPIs | 79750010102024 |
| GCN Sequence Number | 001218 |
| GCN Sequence Number Description | sodium chloride 0.9 % (flush) SYRINGE 0.9 % INJECTION |
| HIC3 | C1B |
| HIC3 Description | SODIUM/SALINE PREPARATIONS |
| GCN | 03020 |
| HICL Sequence Number | 045574 |
| HICL Sequence Number Description | SODIUM CHLORIDE 0.9 % (FLUSH) |
| Brand/Generic | Generic |
| Proprietary Name | SODIUM CHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sodium chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVASCULAR |
| Active Ingredient Strength | 0.9 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Liebel-Flarsheim Company LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021569 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00019-1188-81 (00019118881)
| NDC Package Code | 0019-1188-81 |
|---|---|
| Billing NDC | 00019118881 |
| Package | 20 BOX in 1 CARTON (0019-1188-81) / 1 SYRINGE, PLASTIC in 1 BOX / 125 mL in 1 SYRINGE, PLASTIC |
| Marketing Start Date | 2012-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |